Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $37,393 | $37,685 | $34,991 | $36,808 |
| - Cash | $12,959 | $13,716 | $13,524 | $13,508 |
| + Debt | $32,211 | $32,064 | $31,697 | $29,767 |
| Enterprise Value | $56,644 | $56,034 | $53,164 | $53,067 |
| Revenue | $10,094 | $9,420 | $10,155 | $10,449 |
| % Growth | 7.2% | -7.2% | -2.8% | – |
| Gross Profit | $4,891 | $4,500 | $4,679 | $5,023 |
| % Margin | 48.5% | 47.8% | 46.1% | 48.1% |
| EBITDA | $1,694 | $1,677 | $1,462 | $1,819 |
| % Margin | 16.8% | 17.8% | 14.4% | 17.4% |
| Net Income | $937 | $765 | $759 | $786 |
| % Margin | 9.3% | 8.1% | 7.5% | 7.5% |
| EPS Diluted | 0.35 | 0.29 | 0.29 | 0.3 |
| % Growth | 20.7% | 0% | -3.3% | – |
| Operating Cash Flow | $1,078 | $1,056 | $0 | $1,863 |
| Capital Expenditures | -$955 | -$1,119 | -$1,383 | -$934 |
| Free Cash Flow | $123 | -$63 | $107 | $146 |